{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T06:18:04Z","timestamp":1783837084082,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Dutch Medicines Evaluation Board"},{"name":"Dutch Health and Youth Care Inspectorate"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Drug recalls occur regularly with some resulting in medication switches for patients. Limited research into this topic suggests that drug recalls can lead to anxiety and unrest for patients which in turn can affect confidence in and use of medication. In this context, a better understanding of patient perceptions and communication preferences is essential to adequately handle drug recalls and ensure continued medication adherence and trust.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The aim of this study was to elucidate patients\u2019 experiences, perceptions, and preferences regarding drug recalls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This qualitative study comprised focus group discussions with patients that experienced a drug recall, recruited through pharmacies from distinct locations in the Netherlands. We aimed to conduct at least two focus groups, each comprising a minimum of six participants. Audio recordings were transcribed verbatim and analyzed using a thematic analysis approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>It was found that patients had limited knowledge of drug recall procedures, often confused them with shortages, and struggled to interpret associated risks. Communication was frequently perceived as unclear, triggering varied emotional responses and, in some cases, reduced trust in and use of medications. Patients preferred pharmacist-led, personalized communication tailored to recall urgency, and emphasized the importance of shared decision-making, particularly during medication substitutions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Drug recalls cause a range of emotions in patients, leading to reduced confidence and use of medication in some patients. Preferences centered on understandable, transparent, and personalized communication led by pharmacists. The findings of this study emphasize the importance of embedding patient engagement and tailored communication within pharmacovigilance systems to maintain trust and support shared decision-making during drug recalls.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11096-025-02082-z","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T12:19:33Z","timestamp":1768393173000},"page":"864-873","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patient perspectives on drug recalls in the Netherlands: a qualitative study"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1660-180X","authenticated-orcid":false,"given":"Pieter A.","family":"Annema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4541-2140","authenticated-orcid":false,"given":"Lenny M. W. Nahar-van","family":"Venrooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4596-0684","authenticated-orcid":false,"given":"Marcel L.","family":"Bouvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4292-532X","authenticated-orcid":false,"given":"Rob J.","family":"van Marum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1658-3100","authenticated-orcid":false,"given":"Hieronymus J.","family":"Derijks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"2082_CR1","unstructured":"European Medicines Agency. Human Regulatory-Quality defects and recalls. https:\/\/www.ema.europa.eu\/en\/human-regulatory\/post-authorisation\/compliance\/quality-defects-recalls. Accessed 18 Feb 2025."},{"key":"2082_CR2","unstructured":"Food and Drug Administration. Recalls Background and Definitions. https:\/\/www.fda.gov\/safety\/industry-guidance-recalls\/recalls-background-and-definitions. Accessed 18 Feb 2025."},{"key":"2082_CR3","unstructured":"European Medicines Agency. Management of rapid alerts arising from quality defects risk assessment. 2024. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/research-development\/compliance-research-development\/good-manufacturing-practice\/compilation-union-procedures-inspections-exchange-information. Accessed 17 Feb 2025."},{"issue":"6","key":"2082_CR4","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/cpt.3220","volume":"115","author":"PA Annema","year":"2024","unstructured":"Annema PA, Derijks HJ, Bouvy ML, et al. Impact of drug recalls on patients in the Netherlands: a 5-year retrospective data analysis. Clin Pharmacol Ther. 2024;115(6):1365\u201371. https:\/\/doi.org\/10.1002\/cpt.3220.","journal-title":"Clin Pharmacol Ther"},{"key":"2082_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2023.111472","volume":"174","author":"R te Paske","year":"2023","unstructured":"te Paske R, Vervloet M, Linn AJ, et al. The impact of trust in healthcare and medication, and beliefs about medication on medication adherence in a Dutch medication-using population. J Psychosom Res. 2023;174:111472. https:\/\/doi.org\/10.1016\/j.jpsychores.2023.111472.","journal-title":"J Psychosom Res"},{"issue":"7","key":"2082_CR6","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3390\/pharmaceutics13071100","volume":"13","author":"K Kvarnstr\u00f6m","year":"2021","unstructured":"Kvarnstr\u00f6m K, Westerholm A, Airaksinen M, et al. Factors contributing to medication adherence in patients with a chronic condition: a scoping review of qualitative research. Pharmaceutics. 2021;13(7):1100. https:\/\/doi.org\/10.3390\/pharmaceutics13071100.","journal-title":"Pharmaceutics"},{"issue":"1","key":"2082_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/14737167.2023.2266135","volume":"24","author":"AP Kengne","year":"2024","unstructured":"Kengne AP, Bri\u00e8re J-B, Zhu L, et al. Impact of poor medication adherence on clinical outcomes and health resource utilization in patients with hypertension and\/or dyslipidemia: systematic review. Expert Rev Pharmacoecon Outcomes Res. 2024;24(1):143\u201354. https:\/\/doi.org\/10.1080\/14737167.2023.2266135.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"2082_CR8","doi-asserted-by":"publisher","first-page":"1444012","DOI":"10.3389\/fphar.2024.1444012","volume":"15","author":"P Kardas","year":"2024","unstructured":"Kardas P, Bennett B, Borah B, et al. Medication non-adherence: reflecting on two decades since WHO adherence report and setting goals for the next twenty years. Front Pharmacol. 2024;15:1444012. https:\/\/doi.org\/10.3389\/fphar.2024.1444012.","journal-title":"Front Pharmacol"},{"issue":"4","key":"2082_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4065\/mcp.2010.0575","volume":"86","author":"MT Brown","year":"2011","unstructured":"Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304\u201314. https:\/\/doi.org\/10.4065\/mcp.2010.0575.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"2082_CR10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.2174\/157016209789346264","volume":"7","author":"A Giannattasio","year":"2009","unstructured":"Giannattasio A, Barbarino A, Lo Vecchio A, et al. Effects of Antriretroviral Drug Recall on perception of Therapy Benefits. Curr HIV Res. 2009;7(5):468\u201372. https:\/\/doi.org\/10.2174\/157016209789346264.","journal-title":"Curr HIV Res"},{"issue":"6","key":"2082_CR11","first-page":"1082","volume":"33","author":"GA Hawker","year":"2006","unstructured":"Hawker GA, Katz JN, Solomon DH. The patients perspective on the recall of Vioxx. J Rheumatol. 2006;33(6):1082\u20138.","journal-title":"J Rheumatol"},{"issue":"9","key":"2082_CR12","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/ajh\/hpab046","volume":"34","author":"M Krousel-Wood","year":"2021","unstructured":"Krousel-Wood M, Craig LS, Peacock E, et al. Medication adherence: expanding the conceptual framework. Am J Hypertens. 2021;34(9):895\u2013909. https:\/\/doi.org\/10.1093\/ajh\/hpab046.","journal-title":"Am J Hypertens"},{"key":"2082_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnsa.2024.100174","volume":"6","author":"S Rahimi","year":"2024","unstructured":"Rahimi S, Khatooni M. Saturation in qualitative research: an evolutionary concept analysis. Int J Nurs Stud Adv. 2024;6:100174. https:\/\/doi.org\/10.1016\/j.ijnsa.2024.100174.","journal-title":"Int J Nurs Stud Adv"},{"key":"2082_CR14","doi-asserted-by":"publisher","first-page":"100171","DOI":"10.1016\/j.glmedi.2024.100171","volume":"5","author":"SK Ahmed","year":"2025","unstructured":"Ahmed SK. Sample size for saturation in qualitative research: debates, definitions, and strategies. J Med Surg Public Health. 2025;5:100171. https:\/\/doi.org\/10.1016\/j.glmedi.2024.100171.","journal-title":"J Med Surg Public Health"},{"issue":"9","key":"2082_CR15","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/acm.0000000000000388","volume":"89","author":"BC O\u2019Brien","year":"2014","unstructured":"O\u2019Brien BC, Harris IB, Beckman TJ, et al. Standards for reporting qualitative research. Acad Med. 2014;89(9):1245\u201351. https:\/\/doi.org\/10.1097\/acm.0000000000000388.","journal-title":"Acad Med"},{"key":"2082_CR16","unstructured":"Eurostat. International Standard Classification of Education (ISCED). https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=International_Standard_Classification_of_Education_(ISCED). Accessed 12 Dec 2025."},{"key":"2082_CR17","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3390\/ijerph21101301","volume":"21","author":"N Pelizzari","year":"2024","unstructured":"Pelizzari N. The challenges for EU user testing policies for patient information leaflets. Int J Environ Res Public Health. 2024;21:1301. https:\/\/doi.org\/10.3390\/ijerph21101301.","journal-title":"Int J Environ Res Public Health"},{"key":"2082_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2023.107944","volume":"116","author":"R Richter","year":"2023","unstructured":"Richter R, Jansen J, Bongaerts I, et al. Communication of benefits and harms in shared decision making with patients with limited health literacy: a systematic review of risk communication strategies. Patient Educ Couns. 2023;116:107944. https:\/\/doi.org\/10.1016\/j.pec.2023.107944.","journal-title":"Patient Educ Couns"},{"issue":"6","key":"2082_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/psb.1993","volume":"33","author":"D Laight","year":"2022","unstructured":"Laight D. Risk communication: a pillar of shared decision making. Prescriber. 2022;33(6):24\u20138. https:\/\/doi.org\/10.1002\/psb.1993.","journal-title":"Prescriber"},{"issue":"4","key":"2082_CR20","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.pec.2017.11.010","volume":"101","author":"M Heringa","year":"2018","unstructured":"Heringa M, Floor-Schreudering A, De Smet P, et al. Aspects influencing patients\u2019 preferences for the management of drug-drug interactions: a focus group study. Patient Educ Couns. 2018;101(4):723\u20139. https:\/\/doi.org\/10.1016\/j.pec.2017.11.010.","journal-title":"Patient Educ Couns"},{"key":"2082_CR21","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1186\/1472-6947-13-S2-S7","volume":"13","author":"LJ Trevena","year":"2013","unstructured":"Trevena LJ, Zikmund-Fisher BJ, Edwards A, et al. Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC Med Inform Decis Mak. 2013;13:S7. https:\/\/doi.org\/10.1186\/1472-6947-13-S2-S7.","journal-title":"BMC Med Inform Decis Mak"},{"key":"2082_CR22","unstructured":"Hochbaum GM. Public participation in medical screening programs: a socio-psychological study: U.S. Department of Health, Education, and Welfare, Public Health Service, Bureau of State Services, Division of Special Health Services, Tuberculosis Program. 1958."},{"issue":"3","key":"2082_CR23","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s11747-023-00967-x","volume":"52","author":"S Raithel","year":"2023","unstructured":"Raithel S, Hock SJ, Mafael A. Product recall effectiveness and consumers\u2019 participation in corrective actions. J Acad Mark Sci. 2023;52(3):716\u201335. https:\/\/doi.org\/10.1007\/s11747-023-00967-x.","journal-title":"J Acad Mark Sci"},{"issue":"10","key":"2082_CR24","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s40264-022-01222-y","volume":"45","author":"M van Hoof","year":"2022","unstructured":"van Hoof M, Chinchilla K, Harmark L, et al. Factors contributing to best practices for patient involvement in pharmacovigilance in Europe: a stakeholder analysis. Drug Saf. 2022;45(10):1083\u201398. https:\/\/doi.org\/10.1007\/s40264-022-01222-y.","journal-title":"Drug Saf"},{"issue":"9","key":"2082_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0308624","volume":"19","author":"T Woodcock","year":"2024","unstructured":"Woodcock T, Lovett D, Ihenetu G, et al. Polypharmacy in primary care: a population-based retrospective cohort study of electronic health records. PLoS ONE. 2024;19(9):e0308624. https:\/\/doi.org\/10.1371\/journal.pone.0308624.","journal-title":"PLoS ONE"},{"key":"2082_CR26","doi-asserted-by":"publisher","first-page":"5694","DOI":"10.22605\/rrh5694","volume":"20","author":"S Javanparast","year":"2020","unstructured":"Javanparast S, Naqvi SKA, Mwanri L. Health service access and utilisation amongst culturally and linguistically diverse populations in regional South Australia: a qualitative study. Rural Remote Health. 2020;20. https:\/\/doi.org\/10.22605\/rrh5694.","journal-title":"Rural Remote Health"},{"issue":"2","key":"2082_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/10810730.2016.1207115","volume":"21","author":"D Levin-Zamir","year":"2016","unstructured":"Levin-Zamir D, Baron-Epel OB, Cohen V, et al. The association of health literacy with health behavior, socioeconomic indicators, and self-assessed health from a national adult survey in Israel. J Health Commun. 2016;21(2):61\u20138. https:\/\/doi.org\/10.1080\/10810730.2016.1207115.","journal-title":"J Health Commun"},{"key":"2082_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/cky214.283","author":"S Park","year":"2018","unstructured":"Park S, Lee H, Kang M. Factors affecting health literacy among immigrants\u2014systematic review. Eur J Public Health. 2018. https:\/\/doi.org\/10.1093\/eurpub\/cky214.283.","journal-title":"Eur J Public Health"},{"key":"2082_CR29","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s12913-017-2276-2","volume":"17","author":"M Van Der Gaag","year":"2017","unstructured":"Van Der Gaag M, Van Der Heide I, Spreeuwenberg PMM, et al. Health literacy and primary health care use of ethnic minorities in the Netherlands. BMC Health Serv Res. 2017;17. https:\/\/doi.org\/10.1186\/s12913-017-2276-2.","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"2082_CR30","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1093\/eurpub\/ckv043","volume":"25","author":"K S\u00f8rensen","year":"2015","unstructured":"S\u00f8rensen K, Pelikan JM, R\u00f6thlin F, et al. Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU). Eur J Public Health. 2015;25(6):1053\u20138. https:\/\/doi.org\/10.1093\/eurpub\/ckv043.","journal-title":"Eur J Public Health"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-02082-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-025-02082-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-02082-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:16:43Z","timestamp":1778746603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-025-02082-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2082"],"URL":"https:\/\/doi.org\/10.1007\/s11096-025-02082-z","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Marcel L. Bouvy is a member of the Dutch Medicines Evaluation Board (MEB). Rob J. van Marum was a member of the Dutch MEB until September 1, 2023.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"After reviewing the study protocol, the Medical Ethics Review Board Brabant found that a full ethical review was not required under Dutch regulations for human research, since the study did not affect the health or well-being of participants (NW2023-69).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Participants received a Participant Information Form (PIF) detailing the study's purpose, and procedures including publication of the results. Participants provided written informed consent before engaging in any study activities.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and publish"}}]}}